论文部分内容阅读
目的观察和评价胰激肽原酶在治疗糖尿病肾病方面的作用。方法41例糖尿病肾病患者应用胰激肽原酶肌注和口服8周。结果治疗有效率72%,治疗前后差异有显著性(P<0.01)。结论胰激肽原酶治疗糖尿病肾病疗效显著。
Objective To observe and evaluate the role of kallidinogenase in the treatment of diabetic nephropathy. Methods 41 patients with diabetic nephropathy were treated with intramuscular injection of pancreatic kininogen and orally for 8 weeks. Results The effective rate of treatment was 72%, with significant difference before and after treatment (P <0.01). Conclusion pancreatic kallikrein treatment of diabetic nephropathy significant effect.